elafin Inhibitors
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
Lactacystin, a proteasome inhibitor, directly inhibits Elafin by preventing its degradation through the ubiquitin-proteasome system. By inhibiting proteasomal activity, Lactacystin increases Elafin levels, leading to its accumulation and potential modulation of its inhibitory function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG-132, a proteasome inhibitor, directly inhibits Elafin by preventing its degradation through the ubiquitin-proteasome system. By inhibiting proteasomal activity, MG-132 increases Elafin levels, leading to its accumulation and potential modulation of its inhibitory function. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $134.00 $215.00 $440.00 $496.00 | 19 | |
Epoxomicin, a proteasome inhibitor, directly inhibits Elafin by preventing its degradation through the ubiquitin-proteasome system. By inhibiting proteasomal activity, Epoxomicin increases Elafin levels, leading to its accumulation and potential modulation of its inhibitory function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib, a proteasome inhibitor, directly inhibits Elafin by preventing its degradation through the ubiquitin-proteasome system. By inhibiting proteasomal activity, Bortezomib increases Elafin levels, leading to its accumulation and potential modulation of its inhibitory function. | ||||||
α-Iodoacetamide | 144-48-9 | sc-203320 | 25 g | $250.00 | 1 | |
Iodoacetamide, a cysteine protease inhibitor, directly inhibits Elafin by targeting cysteine residues involved in its inhibitory function. By blocking cysteine protease activity, Iodoacetamide modulates the function of Elafin, potentially affecting its inhibitory role in relevant pathways. | ||||||
Z-FA-FMK | 197855-65-5 | sc-201303 sc-201303A | 1 mg 5 mg | $125.00 $365.00 | 19 | |
Z-FA-FMK, a caspase inhibitor, indirectly inhibits Elafin by preventing caspase-mediated cleavage or activation that may regulate Elafin function. By inhibiting caspase activity, Z-FA-FMK can influence the downstream events related to Elafin, potentially modulating its inhibitory function. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $165.00 $214.00 $396.00 $617.00 $4804.00 | 19 | |
Marimastat, a matrix metalloproteinase (MMP) inhibitor, indirectly inhibits Elafin by preventing MMP-mediated cleavage or activation that may regulate Elafin function. By inhibiting MMP activity, Marimastat can influence the downstream events related to Elafin, potentially modulating its inhibitory function. | ||||||
TAPI-2 | 187034-31-7 | sc-205851 sc-205851A | 1 mg 5 mg | $280.00 $999.00 | 15 | |
TAPI-2, a TNF-α converting enzyme (TACE) inhibitor, indirectly inhibits Elafin by preventing TACE-mediated cleavage or activation that may regulate Elafin function. By inhibiting TACE activity, TAPI-2 can influence the downstream events related to Elafin, potentially modulating its inhibitory function. | ||||||
ALLM (Calpain Inhibitor) | 136632-32-1 | sc-201268 sc-201268A | 5 mg 25 mg | $140.00 $380.00 | 23 | |
ALLM, a calpain inhibitor, indirectly inhibits Elafin by preventing calpain-mediated cleavage or activation that may regulate Elafin function. By inhibiting calpain activity, ALLM can influence the downstream events related to Elafin, potentially modulating its inhibitory function. | ||||||
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $119.00 $447.00 | 28 | |
Calpeptin, a calpain inhibitor, indirectly inhibits Elafin by preventing calpain-mediated cleavage or activation that may regulate Elafin function. By inhibiting calpain activity, Calpeptin can influence the downstream events related to Elafin, potentially modulating its inhibitory function. | ||||||